Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Denali Therapeutics Inc. (DNLI)

Compare
12.29
-1.31
(-9.60%)
At close: April 1 at 4:00:01 PM EDT
12.45
+0.16
+(1.30%)
After hours: April 1 at 6:53:17 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
330,531
108,463
48,661
Operating Expense
501,878
501,878
527,230
449,207
344,412
Operating Income
-501,878
-501,878
-196,699
-340,744
-295,751
Net Non Operating Interest Income Expense
64,636
64,636
51,505
14,774
4,595
Other Income Expense
14,537
14,537
--
--
--
Pretax Income
-422,705
-422,705
-145,194
-325,970
-291,156
Tax Provision
68
68
30
21
-575
Net Income Common Stockholders
-422,773
-422,773
-145,224
-325,991
-290,581
Diluted NI Available to Com Stockholders
-422,773
-422,773
-145,224
-325,991
-290,581
Basic EPS
-2.76
-2.57
-1.06
-2.60
-2.39
Diluted EPS
-2.76
-2.57
-1.06
-2.60
-2.39
Basic Average Shares
156,505.74
164,473.77
137,370.90
125,530.70
121,524.80
Diluted Average Shares
156,505.74
164,473.77
137,370.90
125,530.70
121,524.80
Total Operating Income as Reported
-487,341
-487,341
-196,699
-340,744
-295,751
Total Expenses
501,878
501,878
527,230
449,207
344,412
Net Income from Continuing & Discontinued Operation
-422,773
-422,773
-145,224
-325,991
-290,581
Normalized Income
-434,257.23
-434,257.23
-145,224
-325,991
-290,581
Interest Income
64,636
64,636
51,505
14,774
4,595
Net Interest Income
64,636
64,636
51,505
14,774
4,595
EBIT
-501,878
-501,878
-196,699
-340,744
-295,751
EBITDA
-492,886
-492,886
-179,973
-330,361
-287,158
Reconciled Depreciation
8,992
8,992
16,726
10,383
8,593
Net Income from Continuing Operation Net Minority Interest
-422,773
-422,773
-145,224
-325,991
-290,581
Total Unusual Items Excluding Goodwill
14,537
14,537
--
--
--
Total Unusual Items
14,537
14,537
--
--
--
Normalized EBITDA
-507,423
-507,423
-179,973
-330,361
-287,158
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
3,052.77
3,052.77
--
--
--
12/31/2021 - 12/8/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ZLAB Zai Lab Limited
37.29
+3.18%
 
BPMC Blueprint Medicines Corporation
85.94
-2.90%
 
ARVN Arvinas, Inc.
7.03
+0.14%
 
SLNO Soleno Therapeutics, Inc.
68.26
-4.46%
 
WVE Wave Life Sciences Ltd.
7.74
-4.21%
 
EWTX Edgewise Therapeutics, Inc.
20.13
-8.50%
 
RCUS Arcus Biosciences, Inc.
7.71
-1.78%
 
IMVT Immunovant, Inc.
15.20
-11.06%
 
STOK Stoke Therapeutics, Inc.
6.23
-6.32%
 
BHVN Biohaven Ltd.
22.60
-5.99%